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Polybrominated biphenyl (PBB), a toxic
polyhalogenated aromatic hydrocarbon
with bromine substituted on a biphenyl
ring, was manufactured in the early 1970s
as a fire retardant for use in thermoplastics
and carpets. Most laboratory tests identify
the 2,4,5,2',4',5'-hexabromobiphenyl
component of PBB; this congener
occurred in the largest amounts in com-
mercial preparations (1). PBB is stable and
resists organic degradation; it is insoluble
in water and highly lipophilic (2). PBB in
blood sera can be measured by isothermic
gas chromotography with electron capture
detection, with a lower limit of detection
of 1 ppb and an analytic coefficient of
variation ofbetween 7.1 and 14.0% (3).
PBB came to the attention ofthe pub-
lic in 1974 when it was discovered that
about 1000 pounds had been accidentally
substituted for magnesium oxide as an
additive for cattle feed in Michigan in
1973. Meat and dairy products from cont-
aminated herds were distributed through-
out Michigan. To contain the exposure,
the Michigan Department ofAgriculture
quarantined more than 250 Michigan
farms and eventually destroyed 30,000 cat-
tle, 1.5 million chickens, and other farm
animals, along with their products and by-
products (4). By 1978, 96% ofbreast milk
samples from women living in Michigan's
lower peninsula contained detectable levels
ofPBB (5).
The chemical's short-term toxicity in
animals has been well described. Studies
done in rats and rabbits show that the pri-
mary effect is in the liver, where it induces
hepatocellular carcinomas and other carci-
nomas (6), along with immunologic
effects, accumulation in the fetus, and fetal
abnormalities (7I. The short-term effects of
PBB in humans are disputed; some studies
have noted the appearance ofa "PBB syn-
drome," (8) while others have found no
association between exposure and various
biochemical and medical outcomes (9-11).
The chronic health effects in humans are
also unclear (12).
The purpose of this study was to esti-
mate the half-life of PBB in human blood
sera in order to contribute to our under-
standing of how continued body burden
relates to the possible adverse health conse-
quences of exposure. We found only one
previous report of the half-life of PBB in
humans (13). This study gave a median
estimate of 12 years with a range of
4.6-94.7 years. This estimate was deter-
mined by serum measurements from 15
females and 12 males; the half-life for
females and males was similar. An experi-
mental half-life determined in rats using a
multicompartment model that was then
extrapolated to humans was reported as 6.5
years (14); the elimination ofPBB from rat
serum has been shown to be first order
(15). A linear relationship between PBB
concentrations in adipose tissue and in
serum with a ratio ofapproximately 300:1
has been demonstrated; the different con-
geners of PBB do not have significantly
different partition ratios (16,17).
Methods
We used data and participants from the
Michigan PBB prospective cohort project,
which was started in 1975 and was previ-
ously described by Pirkle et al. (18). The
Michigan investigators enrolled people in
the study if they were residents of farms
quarantined because of PBB in milk
detected at 300 ppb, in eggs detected at 50
ppb (N = 2148), or ifthey were recipients
of food products from quarantined farms
(N = 1421). Participation was over 95%.
Subjects answered a questionnaire, provid-
ed a blood sample, and were followed over
time to contribute new blood samples and
answer follow-up questionnaires.
Participants from the cohort were eligi-
ble for inclusion in our analysis ifthey: 1)
lived on a quarantined farm or consumed
food products from such a farm; 2) had at
least two PBB level determinations
between 1976 and 1982 that were a mini-
mum of 1 year apart; 3) were over 18 years
of age at the time of their first PBB level
measurement; and 4) had an initial PBB
level determination ofat least 20 pbb. We
included the age requirement because con-
tinued growth may affect measured PBB
levels and half-life (19,20). We restricted
the study to those with initial PBB levels
above 20 ppb because the possibility of
continued low-level exposure would have
artificially slowed decline of PBB levels
among those with low initial levels.
Measurements between 1976 and 1982
were used because only initial weight
information on participants was available,
and changing body mass index may affect
half-life. Also, fewer PBB measurements
were made after 1982.
For a one-compartment model using
first-order kinetics, the initial and subse-
quent concentrations of a substance are
related by the formula Ct = Coe t where
C0 represents concentration at initial time,
Ct represents concentration at later times,
and k is the rate ofdecline (21). After tak-
ing logarithms and rearranging, this for-
mula is equivalent to -k = Alog(C)/At,
where Alog(C) is the change in the log of
PBB measurements and Atis the change in
time between the measurements. The esti-
mated half-life is then equal to log(2)/X.
We estimated k for each individual
using simple linear regression of eligible
PBB measurements and the times between
them. We estimated the half-life using two
methods in order to better summarize the
data. The first method used the median of
the individual x values to estimate the half-
life. Confidence intervals (CI) were calcu-
lated using distribution-free techniques
(22). The second method used the mean of
the individual X values. Weighting subjects
according to the number of available PBB
measurements for sensitivity analysis did
not change the results. The SAS system was
used for calculations (SAS Institute, Inc.,
Cary, North Carolina).
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Results
A total of 163 persons met the eligibility
criteria (Table 1). The study population
was 69% male, and 63% lived on quaran-
tined farms. The mean level of PBB was
172.8 ppb (range 20-1900 ppb) and the
median was 45.5 ppb. The mean age in
1975 was 40.4 years (range 18.1-73.5
years), and the mean initial body mass
index in 1975 was 25.2 (range 17.2-40.7).
On average, men had higher PBB levels,
greater body mass index, and were older
than women, whereas people who lived on
quarantined farms had higher mean PBB
levels than others.
Using the median of the individual X
values (Table 2), the estimated half-life of
PBB in human sera was 10.8 years (95%
CI, 9.2-14.7 years). The half-life for
women was 18.5 years (9.5-40.1 years) and
for men was 10.2 years (8.5-12.4 years).
The estimate for residents of quarantined
farms was 10.9 years (8.5-15.2 years) and
for consumers of meat and dairy products
from such farms was 10.8 years (8.9-15.8
years). Only in the highest quartile ofbody
mass index was the estimation of half-life
different in men and women (men: 14.2
years, women: infinite years, p<0.01 for the
median test).
Using the mean ofthe individual X val-
ues, the estimated half-life of PBB in
human sera was 10.8 years (95% CI,
7.4-19.9 years). The half-life for women
was 13.0 years (6.3-infinite years) and for
men was 10.0 years (6.7-20.0 years). The
estimate for residents ofquarantined farms
was 10.2 years (7.3-16.6 years) and for
consumers of meat and dairy products
from such farms was 12.1 years (5.7-infi-
nite years).
Tables 3 and 4 present selected charac-
teristics about the PBB measurements used
for this study. Over 65% of participants
contributed two eligible PBB measure-
ments, while most of the remainder pro-
vided three measurements. The amount of
time between the first and last eligible
measurement ranged from 1 to 6 years,
with counts being approximately equal for
spans of 1, 2, 3, and 5 years, and lower for
spans of4 and 6 years.
Discussion
The main strength of this study is that it
represents the first large investigation ofthe
half-life of PBB in humans. After the acci-
dental exposure of the population of
Michigan to PBB, the product was no
longer manufactured. It is no longer a
potential environmental hazard. Therefore,
the information in this study represents a
unique occasion to understand the effects of
PBB. Individual serum values have been col-
lected over almost 20 years since the registry
was begun. The accuracy of the methods
Table 1. The study population by gender and exposure group
Overall
Female
Male
Farmer
Consumer
PBB (ppb)
N Mean Range
163 172.8 20-1900
51 145.8 20-1150
112 185.1 20-1900
102 198.5 20-1900
61 130.0 20-1194
BMI
Mean Range
25.2 17.2-40.7
24.8 17.2-40.7
25.4 19.5-37.1
24.9 17.2-40.7
25.8 19.5-35.2
Age (years)
Mean Range
40.4 18.8-73.5
40.0 18.8-66.0
40.5 18.1-73.5
40.8 18.8-73.5
39.6 18.1-68.5
Abbreviations: PBB, polybrominated biphenyl; BMI, body mass index.
Table 2. Half-life values of polybrominated bi-
phenyl for different groups
Half-life, years (95% Cl)
Group Median Mean
All 10.8 (9.2-14.7) 10.8 (7.4-19.9)
Women 18.5 (9.5-40.1) 13.0 (6.3-infinite)
Men 10.2 (8.5-12.4) 10.0 (6.7-20.0)
Farmers 10.9 (8.5-15.2) 10.2 (7.3-16.6)
Consumers 10.8 (8.9-15.8) 12.1 (5.7-infinite)
used to determine PBB levels was high (23).
This study has several limitations. The
study does not represent a random sample
ofMichigan residents exposed to PBB. It is
heavily weighted to the subpopulation of
farmers who had the most direct exposure
to the compound, their neighbors, and
direct customers. In addition, the study
population was chosen from people who
had a PBB level ofat least 20 ppb. It is not
known how this subset of the cohort may
differ from the entire cohort or from other
Michigan residents. Generalization of the
results ofthis study to the total cohort and
to the population at large must be made
with caution.
PBB levels were not determined at
equal time intervals for all subjects, the
same number of measurements were not
obtained for each subject, and we found
substantial variation in the X values for
each subject. In addition, the body mass
index ofeach subject was only recorded at
initial entry into the registry. Therefore, it
was not possible to control for the effect of
change over time in body mass index on
the estimated value of X. In addition,
blood samples were not uniformly taken
after subjects had fasted. We could not
determine which samples represented fast-
ing PBB levels and which did not.
Therefore, all measurements were used.
PBB is a highly lipophilic compound
which is primarily stored in adipose tissue;
however, not enough adipose samples
were collected to allow the estimation of
PBB adipose half-life. The rate ofequilib-
rium at low levels of contamination
between adipose tissue and blood is not
fully known. However, a very high corre-
lation between adipose tissue and blood
serum for PBB has been shown (17). Also,
lactation is a major route for excretion of
PBB (Davis MK, Centers for Disease
Control, personal communication), but
Table 3. Number of serum samples per participant
No. of samples Count Percent
2 107 65.6
3 50 30.7
4 6 3.7
Table 4. Number of years between first and last
polybrominated biphenyl measurement per par-
ticipant
No. ofyears Count Percent
1 35 21.5
2 37 22.7
3 32 19.6
4 6 3.7
5 42 25.8
6 11 6.7
information on breastfeeding was not
available. However, when we excluded
PBB measurements for women starting 30
days before delivery and up to 180 days
after delivery, the values for the half-life
did not change.
In addition, this study assumed a
point exposure of the cohort to PBB,
(i.e., essentially everyone was exposed to
the contaminant at the same time for the
same amount oftime and then no more).
If continued low-level exposure did
occur, for example, on farms that were
the most heavily contaminated, we may
have overestimated the half-life of PBB
because the analysis did not account for
the possibility of continued exposure.
However, when we split the subjects
based on their first PBB determination
(less than or greater than 100 ppb), there
was no statistically significant difference
between the calculated half-lives for those
with high first measurements and those
with low first measurements, either over-
all or for any of the subgroups
(Wilcoxon, p >0.5).
In conclusion, the estimated PBB half-
life in humans is approximately 11 years,
although the confidence intervals were
quite wide. Thus, the body burden ofPBB
ofexposed people, in the absence of other
exposures, will decrease only gradually over
time. For people with the median level of
exposure (about 45 ppb), it will be more
than 60 years from the time oftheir expo-
sure before their serum levels fall below the
current level ofdetection.
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